1. Home
  2. EKSO vs IMNN Comparison

EKSO vs IMNN Comparison

Compare EKSO & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EKSO
  • IMNN
  • Stock Information
  • Founded
  • EKSO 2005
  • IMNN 1982
  • Country
  • EKSO United States
  • IMNN United States
  • Employees
  • EKSO N/A
  • IMNN N/A
  • Industry
  • EKSO Medical/Dental Instruments
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • EKSO Health Care
  • IMNN Health Care
  • Exchange
  • EKSO Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • EKSO 13.4M
  • IMNN 13.6M
  • IPO Year
  • EKSO N/A
  • IMNN 1985
  • Fundamental
  • Price
  • EKSO $0.55
  • IMNN $0.92
  • Analyst Decision
  • EKSO Strong Buy
  • IMNN Strong Buy
  • Analyst Count
  • EKSO 2
  • IMNN 2
  • Target Price
  • EKSO $5.50
  • IMNN $20.50
  • AVG Volume (30 Days)
  • EKSO 318.5K
  • IMNN 148.4K
  • Earning Date
  • EKSO 03-03-2025
  • IMNN 02-27-2025
  • Dividend Yield
  • EKSO N/A
  • IMNN N/A
  • EPS Growth
  • EKSO N/A
  • IMNN N/A
  • EPS
  • EKSO N/A
  • IMNN N/A
  • Revenue
  • EKSO $17,682,000.00
  • IMNN N/A
  • Revenue This Year
  • EKSO N/A
  • IMNN N/A
  • Revenue Next Year
  • EKSO $32.74
  • IMNN N/A
  • P/E Ratio
  • EKSO N/A
  • IMNN N/A
  • Revenue Growth
  • EKSO 4.12
  • IMNN N/A
  • 52 Week Low
  • EKSO $0.47
  • IMNN $0.57
  • 52 Week High
  • EKSO $2.16
  • IMNN $3.65
  • Technical
  • Relative Strength Index (RSI)
  • EKSO 42.05
  • IMNN 53.96
  • Support Level
  • EKSO $0.50
  • IMNN $0.81
  • Resistance Level
  • EKSO $0.61
  • IMNN $0.93
  • Average True Range (ATR)
  • EKSO 0.04
  • IMNN 0.05
  • MACD
  • EKSO 0.00
  • IMNN -0.00
  • Stochastic Oscillator
  • EKSO 57.33
  • IMNN 68.13

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

About IMNN Imunon Inc.

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

Share on Social Networks: